Colchicina

證據等級: L5

預測適應症: 0 個

Colchicine (Colchicina): Drug Repurposing Evaluation — Data Insufficient for Full Analysis

One-Sentence Summary

Colchicine (Colchicina) is a well-established pharmaceutical compound, but the current Evidence Pack contains no populated original indications, no TxGNN predicted indications, and critical data gaps in mechanism of action and safety information. A meaningful repurposing analysis cannot be completed until these gaps are remediated; this report serves as a status record and remediation roadmap.

Quick Overview

Item	Content
Original Indication	Not populated in Evidence Pack
Predicted New Indication	No TxGNN predictions available
TxGNN Prediction Score	Not available
Evidence Level	Not assessable
Italy Market Status	✗ Not Marketed (0 authorizations found)
Number of Authorizations	0
Recommended Decision	Hold

Italy Market Information

No marketing authorizations were returned from the registry query. Total licenses on record: 0.

Note: The query log confirms the registry search was executed successfully (result_status: "success") but returned 0 records. If Colchicina is known to have market presence in the target territory under an alternate product name or license holder, a targeted product-name search is recommended as a follow-up step.

Safety Considerations

Please refer to the package insert for safety information.

The registry query for the package insert returned 1 result (query_log id: 4), but the content was not transferred to the Evidence Pack. Retrieval and parsing of this document is classified as a Blocking gap (DG001) and must be completed before any safety evaluation can proceed.

Conclusion and Next Steps

Decision: Hold

Rationale: The Evidence Pack contains no TxGNN predicted indications, no original indication data, and two unresolved data gaps — one Blocking and one High severity — that prevent any meaningful repurposing or safety evaluation from being conducted at this time.

To proceed, the following is needed:

[Blocking — DG001] Parse the package insert PDF already retrieved from the registry (query_log id: 4) to extract warnings and contraindications; this is the precondition for entering the S1 safety screening stage
[High — DG002] Query the DrugBank record already identified (query_log id: 3, result_count: 1) to populate the mechanism of action (MOA) field and original indications
[Required] Re-run the TxGNN prediction pipeline with Colchicina as input to generate candidate repurposing indications; without predictions, no repurposing analysis can be initiated
[Advisory] Verify Italy/AIFA marketing authorization status via a product-name search (e.g., "Colchicina Houde" or other known brand names), as the current 0-license result may reflect a query scope limitation rather than true market absence
[Advisory] Confirm DrugBank ID and map to standardized INN to ensure consistent cross-source identification in future pipeline runs
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.